Cipla selects Mobien’s iNotify Platform to roll out stockiest self service portal

PUNE, India - Feb. 24, 2015 - PRLog -- Mobien Technologies is proud to announce that  Cipla Ltd. has chosen its award winning iNotify platform for its mobility and portal deployment. In the first phase, Cipla would deploy stockiest portal for order management and claims management.
Stockiest portal will help Cipla Stockiest’ in uploading and capturing order details, expiry claims and sales return. It will also help the stockiest’ to get notifications on new schemes, new products etc. launched by Cipla. With this, the order booking process will be automated and will connect with backend ERP system seamlessly.

The stockiest self service portal will help stockiests in reducing the turnaround time for their orders. The sales return and claims processing will also be faster. The processing of stockiest’ order will be automated and will be integrated with SAP seamlessly. It would also help stockiests to track their orders, claims and schemes. The portal would allow a multi channel of communication through web access, emails and mobile notifications. Stockiest would also use the portal for issue management via its in-built ticket management system.

Stockiest portal would utilise the native capabilities of iNotify like non-intrusive integration capability with SAP, ability to intercept data via email and file distiller to transform flat files to XML data, to ensure that stockiests are able to place their orders, return claims without much change management.

About Cipla Ltd. :

Cipla, founded in 1935 is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Cipla has 34 manufacturing units in 8 locations across India and has presence in 170 countries.

Cipla manufactures a range of pharmaceutical and personal care products. The company offers active pharmaceutical ingredients (APIs); and formulations in therapeutic areas, such as allergy, analgesic, anti malarial, anti-infectives, cardiology, dermatology and cosmeceuticals, diabetology, gastroenterology, HIV-AIDS, hormones and steroids, iron chelators, musculoskeletal, neuropsychiatry, nutritional and ophthalmic products, oncology, respiratory, urology, and women’s health in various dosage forms. It also provides veterinary products for various animals, including companion, equine, general care, live stock, and poultry. In addition, the company offers inhaled medication and devices, such as dry powder inhalers, single-dose capsule and multi-dose dry powder inhalers, breath-actuated metered dose inhalers, non-static spacers, baby and infant masks, and nasal sprays. Further, it provides consulting, commissioning, plant engineering, and technical know-how transfer and support services.

Cipla has over 2000 products in 65 therapeutic categories available in over 40 dosage forms.

About Mobien Technologies:

Mobien Technologies is a leading enterprise mobility company with focus on delivering sustainable and cost effective solutions. Mobien offers a mobile application framework enabling complex business processes and applications on mobile devices; in real time and independent of network access. From FMCG / Retail to pharmaceuticals to chemical Industries, companies make informed mission critical decisions using Mobien’s enterprise mobility solution that extends key and real time business application information to their field associates. Mobien has led some of the most complex Enterprise Resource Planning (ERP) implementations for Fortune 500 clients who use its technology for taking business processes and the related information management to handheld devices.

http://www.mobientech.com/news-category/cipla-selects-ino...